TITLE

Breast Tumors in Mice Eradicated Using Cancer Vaccine; Findings Could Lead to New Immune Therapy for Breast Cancer

PUB. DATE
September 2005
SOURCE
Ascribe Newswire: Health;9/14/2005, p3
SOURCE TYPE
Newswire
DOC. TYPE
Article
ABSTRACT
This article reports that a team from the University of Pennsylvania School of Medicine has shown that by using a cancer vaccine based on the bacterium Listeria monocytogenes, they can cure mice with established breast tumors. The researchers published their findings in the September 15 issue of the Journal of Immunology. In general, bacteria are good at inducing both innate and adaptive immune responses, activating such immune cells as macrophages, dendritic cells, and T cells. This helps jump-start the immune response to break tolerance.
ACCESSION #
18266410

 

Related Articles

  • Breast Tumors in Mice Eradicated Using Cancer Vaccine; Findings Could Lead to New Immune Therapy for Breast Cancer.  // Ascribe Newswire: Medicine;9/14/2005, p9 

    This article reports that a team from the University of Pennsylvania School of Medicine has shown that by using a cancer vaccine based on the bacterium Listeria monocytogenes, they can cure mice with established breast tumors. The researchers published their findings in the September 15 issue of...

  • Virus infections in tumors pave the way for tumor-directed DC-vaccines. Woller, Norman; K├╝hnel, Florian; Kubicka, Stefan // OncoImmunology;Mar/Apr2012, Vol. 1 Issue 2, p208 

    Effective treatment of solid cancers by tumor-directed DC-vaccines still remains a challenge in clinical oncology. For therapeutic success, knock-down of tumor-specific tolerance appears mandatory before a potent tumor-specific cytotoxic T-cell response can be triggered by DC-vaccinations....

  • An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine. Lai, M.-D.; Chen, C.-S.; Yang, C.-R.; Yuan, S.-Y.; Tsai, J.-J.; Tu, C.-F.; Wang, C.-C.; Yen, M.-C.; Lin, C.-C. // Cancer Gene Therapy;Mar2010, Vol. 17 Issue 3, p203 

    The cytomegalovirus (CMV) promoter is considered to be one of the strongest promoters for driving the in vivo expression of genes encoded by DNA vaccines. However, the efficacy of DNA vaccines has so far been disappointing (particularly in humans), and this might be explained in part by histone...

  • Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model.  // PLoS ONE;2009, Vol. 4 Issue 11, p1 

    The article presents a study examining the efficacy of targeting cancer associated fibroblasts for the treatment of metastatic breast cancer. It is found that cancer associated fibroblasts promote tumor growth and metastasis through their role as key modulators of immune polarization in the...

  • Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Nelson, William G.; Simons, Jonathan W.; Mikhak, Bahar; Chang, Ju-Fay; DeMarzo, Angelo M.; Carducci, Michael A.; Kim, Michael; Weber, Christine E.; Baccala, Angelo A.; Goeman, Marti A.; Clift, Shirley M.; Ando, Dale G.; Levitsky, Hyam I.; Cohen, Lawrence K.; Sanda, Martin G.; Mulligan, Richard C.; Partin, Alan W.; Carter, H. Ballentine; Piantadosi, Steven; Marshall, Fray F. // Cancer Chemotherapy & Pharmacology. Supplement;Jul2000, Vol. 46, pS67 

    When irradiated and administered intradermally as vaccines, cancer cells engineered to secrete high levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) by gene transfer elicit potent anticancer immune responses in a variety of animal tumor models. Upon vaccination, antigens...

  • Neogenix Using Cancer Vaccine Approaches.  // Bioworld Week;7/16/2007, Vol. 15 Issue 29, p3 

    The article reports that Great Neck, New York-based Neogenix Oncology Inc. has been using cancer vaccine approaches to the development of monoclonal antibodies. Neogenix has created chimeric immunogenic tumor-associated antigens (TAAs) isolated from some of the first vaccines ever tested. Its...

  • Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide. Sakakibara, Mitsuru; Kanto, Tatsuya; Hayakawa, Michiyo; Kuroda, Shoko; Miyatake, Hideki; Itose, Ichiyo; Miyazaki, Masanori; Kakita, Naruyasu; Higashitani, Koyo; Matsubara, Tokuhiro; Hiramatsu, Naoki; Kasahara, Akinori; Takehara, Tetsuo; Hayashi, Norio // Cancer Immunology, Immunotherapy;Nov2011, Vol. 60 Issue 11, p1565 

    Dendritic cell (DC) vaccine has been used to treat patients with advanced colorectal cancer (CRC). The results of vaccine-induced clinical responses have not always been satisfactory partially because of DC incompetence. In order to evaluate the feasibility of novel mature DCs for therapeutic...

  • Herbal prostate help. Altshul, Sara // Prevention;Apr2004, Vol. 56 Issue 4, p44 

    Presents a study by researchers at Columbia University on Zyflamend, a supplement that spark apoptosis or cancer cell self-destruction. Herbal extracts included in the supplement; Percentage of cancer cells that commit suicide with the use of the supplement; Speculated reason for the...

  • Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Peek, Elizabeth M.; Li, David R.; Hanwei Zhang; Hyun Pyo Kim; Baohui Zhang; Garraway, Isla P.; Chin, Arnold I. // American Journal of Cancer Research;2012, Vol. 2 Issue 6, p745 

    The development of new cancer therapeutics would benefit from incorporating efficient tumor models that mimic human disease. We have developed a subcutaneous bladder tumor regeneration system that recapitulates primary human bladder tumor architecture by recombining benign human fetal bladder...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics